RhumbLine Advisers
BTMD icon

RhumbLine Advisers’s Biote Corp BTMD Stock Holding History

RhumbLine Advisers’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.9K Sell
15,272
-22,282
-59% -$45.9K ﹤0.01% 3771
2026
Q1 		$50.7K Buy
37,554
+1,326
+4% +$2.67K ﹤0.01% 3586
2025
Q4 		$94.2K Sell
36,228
-3,490
-9% -$9.54K ﹤0.01% 3497
2025
Q3 		$119K Sell
39,718
-373
-0.9% -$1.33K ﹤0.01% 3456
2025
Q2 		$161K Buy
40,091
+3,827
+11% +$14.1K ﹤0.01% 3343
2025
Q1 		$121K Sell
36,264
-1,424
-4% -$6.79K ﹤0.01% 3324
2024
Q4 		$233K Buy
37,688
+3,920
+12% +$22.8K ﹤0.01% 3114
2024
Q3 		$188K Buy
33,768
+5,543
+20% +$37K ﹤0.01% 3267
2024
Q2 		$211K Buy
28,225
+14,404
+104% +$88.8K ﹤0.01% 3200
2024
Q1 		$80.2K Sell
13,821
-259
-2% -$1.3K ﹤0.01% 3510
2023
Q4 		$69.5K Hold
14,080
– – ﹤0.01% 3554
2023
Q3 		$72.1K Buy
14,080
+1,138
+9% +$6.71K ﹤0.01% 3560
2023
Q2 		$87.5K Buy
+12,942
New +$76.8K ﹤0.01% 3556

Other funds holding BTMD

3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BP
Bandera Partners New York $284M AUM 33.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RhumbLine Advisers's BTMD Position: Q2 2026 in Review

RhumbLine Advisers reduced its Biote Corp (BTMD) stake by 59% in Q2 2026, selling an estimated $45.9K and leaving 15,272 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3771.

RhumbLine Advisers first reported a position in BTMD in Q2 2023 and has held it in 13 quarters since. The position peaked at $233K in Q4 2024. 71 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.

  • RhumbLine Advisers held 15,272 shares of Biote Corp worth $28.9K as of Q2 2026.
  • RhumbLine Advisers sold 22,282 Biote Corp shares in Q2 2026, an estimated $45.9K.
  • Biote Corp made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3771 holding.
  • RhumbLine Advisers first reported a position in Biote Corp in Q2 2023 and has held it in 13 quarters since.
  • RhumbLine Advisers's Biote Corp position peaked at $233K in Q4 2024.
  • 71 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.